Universidad del País Vasco/Euskal Herriko Unibertsitatea-ko ikertzaileekin lankidetzan egindako argitalpenak (32)

2024

  1. The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated with a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

2022

  1. Clear Cell Renal Cell Carcinomas with Aggressive Behavior Display Low Intratumor Heterogeneity at the Histological Level

    Current Urology Reports, Vol. 23, Núm. 6, pp. 93-97

2021

  1. (Pro)renin receptor is a novel independent prognostic marker in invasive urothelial carcinoma of the bladder

    Cancers, Vol. 13, Núm. 22

  2. Clinical implications of (Pro)renin receptor (prr) expression in renal tumours

    Diagnostics, Vol. 11, Núm. 2

  3. Soluble pd-l1 is an independent prognostic factor in clear cell renal cell carcinoma

    Cancers, Vol. 13, Núm. 4, pp. 1-17

2020

  1. Altered tissue and plasma levels of fibroblast activation protein-α (FAP) in renal tumours

    Cancers, Vol. 12, Núm. 11, pp. 1-16

2019

  1. A Critical Insight into the Clinical Translation of PD-1/PD-L1 Blockade Therapy in Clear Cell Renal Cell Carcinoma

    Current Urology Reports, Vol. 20, Núm. 1

  2. Precise definition of PTEN C-terminal epitopes and its implications in clinical oncology

    npj Precision Oncology, Vol. 3, Núm. 1

  3. Precise immunodetection of PTEN protein in human neoplasia

    Cold Spring Harbor Perspectives in Medicine, Vol. 9, Núm. 12

  4. Sequential treatment of metastatic renal cancer in a complex evolving landscape

    ANNALS OF TRANSLATIONAL MEDICINE

  5. The coexpression of fibroblast activation protein (FAP) and basal-type markers (CK 5/6 and CD44) predicts prognosis in high-grade invasive urothelial carcinoma of the bladder

    Human Pathology, Vol. 91, pp. 61-68

2018

  1. High levels of intratumor heterogeneity characterize the expression of epithelial-mesenchymal transition markers in high-grade clear cell renal cell carcinoma

    Annals of Diagnostic Pathology, Vol. 34, pp. 27-30

  2. Loss of PD-L1 (SP-142) expression characterizes renal vein tumor thrombus microenvironment in clear cell renal cell carcinoma

    Annals of Diagnostic Pathology, Vol. 34, pp. 89-93

  3. Potential impact of PD-L1 (SP-142) immunohistochemical heterogeneity in clear cell renal cell carcinoma immunotherapy

    Pathology Research and Practice, Vol. 214, Núm. 8, pp. 1110-1114

2017

  1. CD34 immunostaining enhances a distinct pattern of intratumor angiogenesis with prognostic implications in clear cell renal cell carcinoma

    APMIS, Vol. 125, Núm. 2, pp. 128-133

  2. Sleep Apnea and Hypertension: Are There Sex Differences? The Vitoria Sleep Cohort

    Chest, Vol. 152, Núm. 4, pp. 742-750

2016

  1. Fibroblast activation protein predicts prognosis in clear cell renal cell carcinoma

    Human Pathology, Vol. 54, pp. 100-105

  2. Low-grade metastases in high-grade clear cell renal cell carcinomas A clinicopathologic study of 4 cases with an insight into the role of mesenchymal-to-epithelial transition process

    Annals of Diagnostic Pathology, Vol. 20, pp. 13-18

  3. The expression of fibroblast activation protein in clear cell renal cell carcinomas is associated with synchronous lymph node metastases

    PLoS ONE, Vol. 11, Núm. 12

2015

  1. The normal and pathologic renal medulla: A comprehensive overview

    Pathology Research and Practice, Vol. 211, Núm. 4, pp. 271-280